Clinical Trial Update: Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document reports a completed Phase 1/2 clinical trial evaluating a radiolabeled monoclonal antibody in combination with peripheral stem cell transplantation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Epithelial Cancer

Drugs mentioned

• Radiolabeled monoclonal antibody

Snippet

Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED